InsidersTradesSigma
전진바이오팜 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 전진바이오팜 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Chemicals sector, 전진바이오팜 has logged 52 public disclosures. Market capitalisation: €16.5bn. The latest transaction was reported on 19 June 2026 (Other). Among the most active insiders: 이태훈. The full history is free.
52
Insider Decl.
0
Thresholds
·
28 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,538 of 26,211 companies
31.9
score / 100
Value20
Quality44
FCF yld-1.9%
Earn yld-1.2%
EV/EBITDA47.8x
ROE0.1%
Gross mgn28%
Net mgn-1.4%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 June 2026
Declarations52 total
25 of 52 declarations
About 전진바이오팜
Jeonjin Biopharm is a company specializing in the chemical and materials sector. It is listed on the XKRX market.